Literature DB >> 17562173

Ethnic differences in hepatocellular carcinoma: implications for liver transplantation.

Nyingi Kemmer1, Guy Neff, Michelle Secic, Victoria Zacharias, Tiffany Kaiser, Joseph Buell.   

Abstract

Liver transplantation (LT) as a treatment for Hepatocellular Carcinoma (HCC) provides excellent outcomes if restricted to patients who meet the Milan criteria (MC). The aim of this study was to evaluate the influence of ethnicity on eligibility for LT based on the MC. This is a retrospective cohort study of patients diagnosed with HCC at our institution between January 2000 and September 2005. We identified 169 patients, of whom 135 were male (80%), 108 were Caucasian (64%), 29% were African American (AA) and 7% were of other ethnicity. Eighty two patients (49%) met the MC at diagnosis. Age, gender, severity of liver disease or insurance status was not predictive of meeting MC at diagnosis. Ethnicity was the only significant predictor for failure to meet MC. Significantly fewer Caucasians exceeded the MC compared to AA (44 vs. 71%; P = 0.0015). Conclusion AA are more likely to present with HCC that exceeds the MC.

Entities:  

Mesh:

Year:  2007        PMID: 17562173     DOI: 10.1007/s10620-007-9872-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria.

Authors:  Francis Y Yao; Linda Ferrell; Nathan M Bass; Peter Bacchetti; Nancy L Ascher; John P Roberts
Journal:  Liver Transpl       Date:  2002-09       Impact factor: 5.799

2.  Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance.

Authors:  Angelo Sangiovanni; Ersilio Del Ninno; Pierangelo Fasani; Cristina De Fazio; Guido Ronchi; Raffaella Romeo; Alberto Morabito; Roberto De Franchis; Massimo Colombo
Journal:  Gastroenterology       Date:  2004-04       Impact factor: 22.682

Review 3.  Genetics, epidemiology, and cancer disparities: is it black and white?

Authors:  Timothy R Rebbeck; Chanita Hughes Halbert; Pamela Sankar
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

4.  Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study.

Authors:  Jessica A Davila; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2006-01       Impact factor: 11.382

5.  Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.

Authors:  Adrian M Di Bisceglie; Andre C Lyra; Myron Schwartz; Rajender K Reddy; Paul Martin; Gregory Gores; Anna S F Lok; Khozema B Hussain; Robert Gish; David H Van Thiel; Zobair Younossi; Myron Tong; Tarek Hassanein; Luis Balart; Jacquelyn Fleckenstein; Stephen Flamm; Andres Blei; Alex S Befeler
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

6.  Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.

Authors:  Mindie H Nguyen; Ruel T Garcia; Peter W Simpson; Teresa L Wright; Emmet B Keeffe
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

7.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

Review 8.  Cancer disparities by race/ethnicity and socioeconomic status.

Authors:  Elizabeth Ward; Ahmedin Jemal; Vilma Cokkinides; Gopal K Singh; Cheryll Cardinez; Asma Ghafoor; Michael Thun
Journal:  CA Cancer J Clin       Date:  2004 Mar-Apr       Impact factor: 508.702

9.  Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites.

Authors:  Andrew J Muir; Jeffrey D Bornstein; Paul G Killenberg
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

10.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079

View more
  14 in total

1.  Predictors of liver transplant eligibility for patients with hepatocellular carcinoma in a safety net hospital.

Authors:  Amit G Singal; Vincent Chan; Yonas Getachew; Richard Guerrero; Joan S Reisch; Jennifer A Cuthbert
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

2.  Access to liver transplantation in the MELD era: role of ethnicity and insurance.

Authors:  Nyingi Kemmer; Victoria Zacharias; Tiffany E Kaiser; Guy W Neff
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

3.  Approaching horizontal equity in liver transplant from a racial and ethnic perspective.

Authors:  Caitlin vanLith
Journal:  Transl Gastroenterol Hepatol       Date:  2017-12-06

4.  Racial and ethnic disparities in access to liver transplantation.

Authors:  Amit K Mathur; Douglas E Schaubel; Qi Gong; Mary K Guidinger; Robert M Merion
Journal:  Liver Transpl       Date:  2010-09       Impact factor: 5.799

5.  Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma.

Authors:  Jeanette C Yu; Alfred I Neugut; Shuang Wang; Judith S Jacobson; Lauren Ferrante; Vandana Khungar; Emerson Lim; Dawn L Hershman; Robert S Brown; Abby B Siegel
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

Review 6.  Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States.

Authors:  D Tan; A Yopp; M S Beg; P Gopal; A G Singal
Journal:  Aliment Pharmacol Ther       Date:  2013-08-19       Impact factor: 8.171

Review 7.  Race and ethnicity in access to and outcomes of liver transplantation: a critical literature review.

Authors:  A K Mathur; C J Sonnenday; R M Merion
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

8.  Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma.

Authors:  Grace Guzman; Rohini Chennuri; Alexander Chan; Bryan Rea; Ada Quintana; Roshan Patel; Pei-Zhang Xu; Hui Xie; Nissim Hay
Journal:  Dig Dis Sci       Date:  2014-11-08       Impact factor: 3.199

Review 9.  Liver transplantation in the ethnic minority population: challenges and prospects.

Authors:  Nyingi Kemmer; Guy W Neff
Journal:  Dig Dis Sci       Date:  2009-04-24       Impact factor: 3.199

Review 10.  Hepatitis B and C in African Americans: current status and continued challenges.

Authors:  Kimberly A Forde; Orapin Tanapanpanit; K Rajender Reddy
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-28       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.